Year in review: Allergen immunotherapy

Annals of Allergy, Asthma and Immunology

Volumn 114, Issue 3, 2015, Pages 173-174

  Canonica, Giorgio Walter ^a   Compalati, Enrico ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; PLACEBO; ALLERGEN;

ALLERGIC REACTION; DISEASE SEVERITY; DRUG COST; DRUG TOLERABILITY; FOLLOW UP; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; PATIENT COMPLIANCE; PATIENT PREFERENCE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POLLEN ALLERGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHINOCONJUNCTIVITIS; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; TIME TO TREATMENT; TREATMENT DURATION; UNITED STATES; ADVERSE EFFECTS; ECONOMICS; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOTHERAPY; PROCEDURES; TREATMENT OUTCOME;

ALLERGENS; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; TREATMENT OUTCOME;

EID: 84924352101     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.12.024     Document Type: Article

References (8)

1. R. Anolik, A.M. Schwartz, S. Sajjan, and F. Allen-Ramey Patient initiation and persistence with allergen immunotherapy Ann Allergy Asthma Immunol 113 2014 101 107
2. C.A. Coop, S.K. Yip, and M.S. Tankersley Perceptions regarding injection number and technique Ann Allergy Asthma Immunol 113 2014 227 228
3. M. Guenechea-Sola, S.R. Hariri, A. Galoosian, and J.S. Yusin A retrospective review of veterans' adherence to allergen immunotherapy over 10 years Ann Allergy Asthma Immunol 112 2014 79 81
4. C.L. Holland, K.M. Samuels, J.L. Baldwin, and M.J. Greenhawt Systemic reactions to inhalant immunotherapy using 1:1 target dosing Ann Allergy Asthma Immunol 112 2014 453 458
5. J.W. Steinke, and M.G. Lawrence T-cell biology in immunotherapy Ann Allergy Asthma Immunol 112 2014 195 199
6. J. Maloney, D.I. Bernstein, and H. Nelson Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial Ann Allergy Asthma Immunol 112 2014 146 153
7. T.Z. Kralimarkova, T.A. Popov, and M. Staevska Objective approach for fending off the sublingual immunotherapy placebo effect in subjects with pollenosis: double-blinded, placebo-controlled trial Ann Allergy Asthma Immunol 113 2014 108 113
8. H. Nolte, N. Amar, and D.I. Bernstein Safety and tolerability of a short ragweed sublingual immunotherapy tablet Ann Allergy Asthma Immunol 113 2014 93 100